electroCore Touts 30% Growth Outlook, VA Opportunity at LD Micro Conference

Interim President and CFO Joshua Lev said the bioelectronic technology company is focused on expanding its non-invasive vagus nerve stimulation platform across federal health care, commercial ...

electroCore Announces First Quarter 2026 Financial Results

First quarter 2026 net sales of $9.6 million, an increase of 43% over $6.7 million in the first quarter 2025Net loss of $5.3 million with ...

/C O R R E C T I O N -- Radial Health, Inc./

Radial, a national clinic network delivering the most advanced brain medicine treatments for mental health conditions, today celebrates the news that Blue Cross Blue Shield of South Carolina has appro ...
manilatimes

electroCore Product Line Featured in Documentary Underscoring the Expanding Clinical and Commercial Role of Vagus Nerve Stimulation

ROCKAWAY, N.J., April 23, 2026 (GLOBE NEWSWIRE)-- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced its participation in Hacking the ...
The Manila Times

electroCore Announces Publication in JAMA Highlighting the Benefits of Adding Quell Electrical Nerve Stimulation to Outpatient Physical Therapy in Fibromyalgia

ROCKAWAY, N.J., May 13, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today the publication of new clinical ...

electroCore to Present at the Market Movers Investor Summit on May 5, 2026

ROCKAWAY, N.J., April 28, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will be participating in ...
Seeking Alpha

electroCore, Inc. (ECOR) Q1 2026 Earnings Call Transcript

Greetings, and welcome to the electroCore First Quarter 2026 Earnings Conference Call. [Operator Instructions]. As a reminder, this conference is being recorded. Earlier today, electroCore published ...
The Globe and Mail

electroCore Announces First Patient Enrollment in Investigator-Led Study of gammaCore™ nVNS for PTSD

ROCKAWAY, N.J., April 07, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today the enrollment of the first eight ...
2UrbanGirls on MSN

Best vagus nerve stimulation device | Top 4 of 2026

Vagus nerve stimulation has moved from a clinical curiosity into the consumer wellness mainstream. Five years ago, the o ...
The American Journal of Managed Care

Noninvasive Vagus Nerve Stimulation in a Primary Care Setting: Effects on Quality of Life and Utilization Measures in Multimorbidity Patients With or Without Primary Headache

An audit of medical records of patients who were invited to participate and subsequently prescribed gammaCore for multimorbidity disorders in the UK was conducted. Patient Population and Exclusion ...
Everyday Health on MSN

How to get rid of a headache or migraine attack fast

Get the facts about quick headache, migraine, and cluster headache treatments, including medications and home remedies.